A Barchart report today shows unusually heavy volume in out-of-the-money (OTM) put options in Novo Nordisk, which makes Ozempic and Wegovy. NVO stock has been moving up, so is it overvalued now?

This position may be the strongest overall this offseason, but some of the top names have already agreed to stay put.

ESPN's Stephen A. Smith is not pleased with how the WNBA has treated Fever guard Caitlin Clark amid recent flagrant foul ...

SpaceX stock has advanced in the double digits since its IPO.

Return-to-work (RTW) programs are among the most effective drivers of successful workers' compensation outcomes, improving ...

The intersection of the two is what makes sports so great!

Ally Financial reports vacation overspending is common, but you can recover by assessing your debt, creating a repayment plan ...

It’s one of the fastest-growing places in the UK – nearly trebling its housing stock in the last 60 years – yet the housing problems of locals have significantly worsened. The bill would offer a range ...

Xiaomi’s latest T-series Pro phone delivers Leica-tuned cameras, excellent battery life, strong gaming performance, and a polished design, though its size and software quirks may not be for ...

Reinsurance as an asset class now deserves a place among KKR's latest Capital Market Assumptions (CMAs), with the investment ...

Starting July 4, families can begin contributing to new Trump Accounts, officially known as 530A accounts, for children.The ...